ARCHIVES

Rosenberg Starts New Study With TIL; LAK-IL-2 Costs Clarified

This article is from The Cancer Letter archive.

Vol. 12 No. 46 | November 28, 1986

Download PDF Visit The Full Archive

Related Articles

NCI Implements Changes To Speed Up New Drug Development; compounds In Pipeline Listed

July 9, 1976

FDA Approves Ixempra For Metastatic Breast Cancer Resistant To Other Therapy

October 26, 2007

Bioassay Report Clears EDTA

August 12, 1977

NCCAM Awards To Establish Two Cancer Research Centers.

October 13, 2000

Einhorn Sees More Results Coming Similar to Big Successes in Testicular Cancer

May 15, 1981

Trials Approved by NCI CTEP For the Month of April

April 27, 2012